Pharma

journey path light sunshine stairs climb reach
Pharma

Outlook wins FDA appeal after formal dispute proceedings

After a formal dispute resolution process, the FDA has decided that Outlook's eye drug candidate Lytenava has shown evidence of effectiveness.
Zoey Becker May 27, 2026 8:26am
graphic image of China flags overlapping with US flags
Favicon Fierce Biotech

Will COINS Act kill China biotech licensing boom?

May 26, 2026 3:50pm
Top Line Podcast - ZS

Designing an agentic, future‑ready tech roadmap for emerging pharma

Brought to you by ZS
Food and Drug Administration

Regulatory tracker: Braftovi nets colorectal cancer wins abroad

May 26, 2026 11:08am
Real-World Evidence in the AI Era What You Can Unlock Depends on What You Build On

RWE in the AI Era: What You Unlock Depends on What You Build On

Brought to you by Flatiron Health
cancer target detection radiopharma radio

Lantheus considers potential $7B Curium buyout proposal: report

May 26, 2026 10:38am